AIM ImmunoTech Inc. (AIM)

Tower Resources tops up working capital as farm-out moves closer to completion

Cavendish lifts Optima Health target as annual profit beats forecasts

Moog Celebrates 75 Years of Innovation with New Advanced Integrated Manufacturing Facility, Workforce Investment and STEM Scholarship Initiative

AIM ImmunoTech CEO Highlights Biodefense and Military Force Protection in Newly Published ‘Breaking Defense' Article

Bravura Solutions shares climb as AIM newbie marks 76% jump in cash earnings

Thruvision shares surge 46% to 0.91p on £3m Asian airport contract

Major boon predicted for Jersey Oil & Gas as bullish broker repeats Buy rating

AIM ImmunoTech Ahead of Schedule on ‘Last Dose' DURIPANC Critical Clinical Inflection Point

Admission to Trading on the Main Market and AIM Cancellation

Cavendish sees 18-fold upside at 88 Energy on Alaska prospect scale

Seeing Machines wins European carmaker deal as EU driver monitoring rules come into force

CelLBxHealth builds £3.5m weighted pipeline as revenue growth target held

AIM ImmunoTech Announces Release of New CEO Corner Segment Highlighting Growing Momentum Across Pancreatic Cancer Program

AIM ImmunoTech Announces Release of New CEO Corner Segment Highlighting Growing Momentum Across Pancreatic Cancer Program

Coiled Therapeutics develops improved formulation of experimental cancer drug ahead of trial expansion

Phoenix Copper shares drop on discount equity raise

Greatland Resources ramp-up continued through June 2026

Update on Intention to Move from AIM to Main Market

AIM ImmunoTech Accelerates Toward Potential Pivotal Pancreatic Cancer Program as Ampligen Continues to Advance Through Key Clinical Milestones

Coiled Therapeutics appoints biotech veteran Craig Tooman to board